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Abstract 
Background: The association between palliative care and life-sustaining treatments for 
patients with dementia is unclear in Asian countries. 
Aim: To analyse the use of palliative care and its association with aggressive treatments 
based on Taiwanese national data. 
Design: A matched cohort study was conducted. The association between intervention and 
outcome was evaluated using conditional logistic regression analyses. 
Setting/participants: The source population comprised 239,633 patients with dementia 
diagnosed between 2002 and 2013. We selected patients who received palliative care between 
2009 and 2013 (the treatment cohort; N=1996) and assembled a comparative cohort 
(N=3992) through 1:2 matching for confounding factors. 
Results: After 2009, palliative care was provided to 3,928 (1.64%) patients of the dementia 
population. The odds ratio for undergoing life-sustaining treatments in the treatment cohort 
versus the comparative cohort was <1 for most treatments (e.g. 0.41 for mechanical 
ventilation (95% confidence interval [CI] 0.35–0.48)). The odds ratio was >1 for some 
treatments (e.g. 1.73 for tube feeding (95% CI 1.54–1.95)). Palliative care was more 
consistently associated with fewer life-sustaining treatments for those with cancer. 
Conclusions: Palliative care is related to reduced life-sustaining treatments for patients with 
dementia. However, except in the case of tube feeding, which tended to be provided 
alongside palliative care regardless of cancer status, having cancer possibly had itself a 
protective effect against the use of life-sustaining treatments. Modifying the eligibility criteria 
for palliative care in dementia, improving awareness on the terminal nature of dementia, and 
facilitating advance planning for dementia patients may be priorities for health policies. 
 
Keywords: cross-cultural comparison, dementia, life-support care, national health programs, 
neoplasms, palliative care 
What is already known about the topic? 
 Although palliative care for dementia is a culture-specific issue, current data from Asian 
populations and countries are insufficient. 
 Taiwan was one of the earliest Asian countries to provide nationwide single-payer 
palliative care for dementia and has offered these services since 2009. 
 What this paper adds 
 Palliative care was used by 1.64% of patients with dementia after 2009 in Taiwan. It was 
associated with reduced utilisation of some life-sustaining treatments, such as haemodialysis, 
most invasive respiratory therapies, and cardiopulmonary resuscitation, but more consistently 
so in patients who also had cancer. 
 Palliative care for patients with dementia was associated with increased use of tube 
feeding, enteral tube insertion and non-invasive positive pressure ventilators especially in 
those without cancer. 
Implications for practice, theory, or policy 
 Malignancy status may influence clinicians’ and relatives’ perception of a terminal 
illness, as well as the paradigm of palliative care practice for patients with dementia. 
 The national health care system could prioritize modification of the eligibility criteria to 
ensure timely introduction of palliative care for patients with dementia and to improve 
public awareness on the terminal nature of dementia. 
Introduction 
Dementia is a neurodegenerative disease that has a substantial impact on the healthcare 
system and presents a large socioeconomic burden.1 As a life-limiting disease without an 
effective curative treatment, dementia is currently one of the major causes of death in 
Western countries and the leading cause in England and Wales.2, 3 A clear need for palliative 
care for patients with dementia calls for an increase in studies and actions targeting the 
delivery of proper health care services including at the end of life.4,5 However, there is a large 
gap in relevant data concerning the policy and service pattern of palliative care and dementia 
in Asian populations and countries.6 
Life-sustaining treatments may cause tremendous physiological and psychosocial burdens for 
patients but may not provide promising benefits on survival outcomes, functional capability, 
quality of life, or family-reported quality of end-of-life care for older people or critically ill 
patients with multiple comorbidities.7-10 Having dementia was associated with a very low 
prevalence rate of admission to intensive care units (ICUs) and invasive respiratory therapies 
in studies in the US and Netherlands and in the Danish nationwide database.11,12 Previous 
surveys in Taiwan, a Chinese culture–based society, found that patients with dementia 
underwent more life-sustaining interventions during their last year of life than their 
counterparts in Western countries and that the use of these life-saving or diagnostic 
procedures at an end-of-life stage differed according to whether patients had dementia, 
cancer, or both.13,14 Cross-cultural differences might explain a gap in the use of medical 
intervention for people with dementia between Taiwan and Western countries and trigger the 
need for further study. 
Previous studies have shown that palliative care was associated with reduced hospital and 
ICU admissions for cancer patients and decreased use of artificial nutrition and hydration and 
referrals to the emergency department (ED) for patients with dementia.15-18 A randomised 
control trial in the US of palliative care for patients with advanced dementia who were 
admitted to the hospital demonstrated that the palliative care intervention did not affect the 
use of feeding tubes or mechanical ventilation or decisions to forgo cardiopulmonary 
resuscitation (CPR).19 However, there have been very few other studies to support the 
evidence base regarding the effect of palliative care on life-sustaining treatments for patients 
with dementia.5 It is also important to examine the benefit of palliative care for dementia in 
Taiwan, and to provide base-line figures, because of the increasing burden of aggressive 
interventions in the national healthcare system and the risk of medically futile treatments for 
suffering patients.20 
The National Health Insurance (NHI) in Taiwan provides a single-payer health service 
scheme and covers 99.9% of Taiwan’s legal residents.21 The NHI has reimbursed the costs of 
all palliative care services for patients with cancer or amyotrophic lateral sclerosis, including 
(i) community palliative care since 1996, (ii) inpatient care in palliative care units (PCUs) in 
acute hospitals since 2000, and (iii) hospital liaison palliative care since 2011.22 Additionally, 
Taiwan was one of the earliest Asian countries to extend NHI-paid palliative care services to 
patients with non-cancerous diseases and has been offering these services since 200923 (The 
eligibility criteria for people with dementia are shown in Table 1). Patients who receive 
palliative care are not restricted to use only comfort-oriented treatments but can obtain any 
medical service in the NHI scheme, making an investigation of the linkage between palliative 
care and life-sustaining treatments possible. 
Palliative care has been gradually accepted as a standard for cancer treatment by clinicians 
and patients during the past three decades in Taiwan.24 The rate of CPR dropped by 54.3% 
between 1997 and 2004 for cancer patients at the same time as the expansion of palliative 
care services and the implementation of the Hospice Palliative Care Act 2000 in Taiwan.25 
Our population-based study in Taiwan aimed to investigate the utilisation of palliative care 
and its association with the following aggressive interventions for patients with dementia and 
to analyse whether the association differed between those with and without cancer during the 




Study design and data source 
We conducted a nationwide cohort study with matched controls using Taiwan’s National 
Health Insurance Research Database (NHIRD), which includes inpatient and ambulatory care 
claims data between 2000 and 2013. The information contained in this database included the 
date of hospitalisation; disease diagnoses based on the International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes; medical expenditures; 
and prescriptions. Because patient identifiers were removed and all patient information was 
analysed anonymously, ethics approval regarding the need for informed patient consent was 
waived by the institutional review board of Chi-Mei Medical Center, Taiwan. 
Cohort definition 
The study population included patients aged 18 years and older who had been newly 
diagnosed with dementia from 2002 to 2013. Dementia was defined by ICD-9-CM codes 
290.1x-209.4x, 291.2, 292.82, 294.1x, 294.8, 331.0, 331.1x, 331.2, or 331.82; at least one 
inpatient record of an ICD-9-CM dementia code; or at least three outpatient records within 1 
year after the first dementia code. As the palliative care payment scheme was extended to 
non-cancer patients in 2009,23 patients with dementia with any palliative care claim before 
2009 were excluded. Those with missing information such as date of birth or gender were 
also excluded (Figure 1). 
Next, patients with dementia who obtained palliative care between 2009 and September 2013 
were selected. Palliative care was identified by the claims and ambulatory care orders in 
PCUs, liaison palliative care, and community palliative care. The upper limit of 
reimbursement was once per week for liaison palliative care and two times per week for 
community care. For each patient who had palliative care, to reduce the potential for 
confounding, two comparative samples were assembled from the patients without palliative 
care by matching for age, gender, cancer status (ICD-9-CM: 140–208), Charlson 
Comorbidity Index, the same year of dementia diagnosis, and index date. The index date was 
defined as the first date of obtaining palliative care for the treatment cohort and the date of 
hospital admission for the comparative cohort. Malignancy status was considered in the 
matching procedure because the paradigm for providing palliative care in conventional 
clinical practice in Taiwan was cancer-based.14,21 
Baseline comorbidities and Charlson Comorbidity Index were defined based on information 
from at least one inpatient record or three outpatient records from within 1 year before the 
index date. Other comorbidities were classified using ICD-9-CM codes: diabetes mellitus, 
coronary artery disease, cerebrovascular disease, and chronic obstructive pulmonary disease. 
Death from 2009 to 2013 was determined if a patient was coded as ‘in-hospital death’ or had 
withdrawn from the NHI programme within 30 days after the last hospital discharge without 
any other health care visits. 
Outcome measurements 
The life-sustaining treatments consisted of enteral tube insertion, tube feeding, blood 
transfusions, haemodialysis, respiratory therapies including non-invasive positive pressure 
ventilators, and cardiopulmonary life-sustaining treatments. Use of these interventions was 
defined as a dichotomous variable. 
Statistical analysis 
Data are presented as frequencies and percentages for categorical variables and as means and 
standard deviations or median and interquartile ranges for continuous variables. To compare 
differences between patients with dementia who had and did not have palliative care, a 
Pearson’s 2 test and Student’s t-test or Wilcoxon rank-sum test were used for categorical and 
continuous variables, respectively. 
A conditional logistic regression model was used to evaluate the association between the use 
of palliative care and life-sustaining treatments in the study cohorts and a subgroup analysis 
of patients with dementia with or without cancer and to calculate the odds ratios (ORs) and 
95% confidence intervals (CIs) after adjusting for other comorbidities. Statistical significance 
was set at a p of <0.05 (two-tailed). SAS 9.4 for Windows (SAS Institute, Inc., Cary, North 
Carolina, USA) was used to conduct all statistical analyses. 
 
Results 
Table 2 presents the distribution of the baseline characteristics of the patients with dementia 
in the source population (N=239,633) and the samples after matching (n=5988). Palliative 
care was provided to 457 patients before 2009 and 3,928 patients after 2009. The overall 
percentage of receiving palliative care among whole dementia population is 1.83% (1.64% 
after 2009). In the source population, patients who had palliative care were older, and there 
were higher proportions of patients with a cancer diagnosis than those without palliative care 
(37.93% and 11.53%, respectively).  
The matched samples comprised 1996 patients who had palliative care (treatment cohort) and 
3992 matched subjects who did not have palliative care (comparative cohort; Table 2, right 
columns). The treatment cohort had a significantly higher percentage of ED visits before the 
index date and a higher mortality during the study period, as well as a shorter survival time 
after registration. 
The length of stay and frequency for three categories of palliative care services for patients 
with dementia are illustrated in Table 3. As for those without cancer, the percentage of liaison 
palliative care use was higher, and the rate of community palliative care use was lower 
(54.88% and 20.12%, respectively) than the corresponding rates in the overall group of cases. 
More than 30% of patients had two or more types of palliative care (Supplementary Figure 
1). 
The association between palliative care and life-sustaining treatments for the matched cohorts 
is presented in Table 4 while the total utilisation of life-sustaining treatments in the source 
population is shown in Supplementary Table 1. Patients receiving palliative care had lower 
odds of undergoing haemodialysis, mechanical ventilation, endotracheal intubation, 
tracheostomy, defibrillation, temporary pacemakers, and CPR than a comparative cohort. 
Conversely, the treatment cohort had a higher utilisation rate and odds of enteral tube 
insertion, tube feeding, and non-invasive ventilator use. 
In a subgroup analysis of those with and without cancer, except for enteral tube insertion and 
tube feeding, palliative care was more consistently associated with fewer life-sustaining 
treatments for those with cancer (Figure 2). Moreover, of the interventions among those 
without cancer, palliative care was only associated with a significantly reduced risk of CPR. 
 
Discussion 
Based on data from the first 5-year period when the pioneer national palliative care scheme 
was extended to non-cancerous diseases in Asia, we found that the rate of palliative care use 
for patients with dementia was 1.64% and that the services remained limited to an end-of-life 
stage (median survival time after service: 36 days). Patients with dementia who received 
palliative care had a decreased risk of undergoing treatments such as invasive respiratory 
therapies and CPR, but had increased odds of enteral tube insertion, tube feeding, and 
non-invasive ventilator use. However, as for palliative care services for patients with 
dementia, malignancy status was also associated with reduced life-sustaining treatments. This 
phenomenon in Taiwan implies that practitioners and families do not sufficiently consider 
advanced dementia a terminal illness such as cancer and that patients without cancer are less 
well recognised in the traditional paradigm of palliative care in a Chinese culture–based 
society, resulting in a lower probability of withholding or withdrawing life-sustaining 
treatments.26 The challenges faced in Taiwan may inform policy in countries that are 
initiating a national palliative care scheme for dementia or for Chinese culture–based areas. 
The high burden imposed by aggressive interventions for patients with dementia in Taiwan 
may be attributed to cultural, legal, and health care policy-related factors. The majority of 
older Taiwanese adults feel that discussing death-related topics is taboo, and this presents a 
barrier to advance care planning (ACP).27 Clinical decision-making often relies solely on 
surrogate decisions made by relatives who lack knowledge of the benefits and burdens of 
life-sustaining treatments.28 Even for dementia patients who have declared their preferences 
in advance, the implementation of ACP could be a challenge; for example, the rate of 
discrepancy between Taiwanese patients and their family caregivers regarding 
treatment-related preferences was found to be 48.3% for tube feeding, 48.5% for CPR, and 
60.3% for mechanical ventilation.26 The prevailing value of life preservation in Chinese 
cultures,29 as well as a lack of a practical mechanism in the Taiwanese legal system that 
protects incompetent patients’ advance choices or best interest, may also result in the frequent 
overriding of their preferences or medical professionals’ suggestions by families to use 
aggressive procedures rather than comfort-only care.30 
The low coverage and late availability of palliative care in Taiwan might also have resulted 
from insufficient background knowledge on the norms and standards of palliative care 
practice for dementia among clinical practitioners and the general population. Moreover, the 
NHI eligibility criteria for palliative care for dementia in Taiwan, which were developed 
according to the symptoms burden and care needs for cancer population, might not be 
applicable for patients with dementia.23,31 Another controversy of current eligibility criteria is 
employing stage 5 on the Clinical Dementia Rating scale,32 which is uncommon in literature 
reviews and we feel it may not convince many neurologists and psychiatrists to refer patients 
to palliative care. The profoundly diminished physical condition of these patients who were 
enrolled based on the criteria for palliative care may explain the high prevalence of long-term 
use of artificial nutrition. 
Cancer, renal failure, respiratory failure, and mechanical ventilation have been found to be 
strong predictors of hospice referral in hospitalised patients with dementia.33 Taiwanese 
patients with dementia were often considered for hospital-based palliative care if they had 
initially undergone a series of life-sustaining treatments to reverse an acute illness or critical 
condition and then encountered the dilemma of withdrawing or withholding the interventions 
because of a poor prognosis.34,35 For the selected life-sustaining treatments in this study, 
families, as well some medical professionals, in Taiwan often consider enteral feeding, blood 
transfusions, non-invasive ventilators, and haemodialysis as less uncomfortable than other 
invasive respiratory therapies and CPR.23,34 Therefore, even after obtaining palliative care, 
withdrawing or withholding the aforementioned interventions may be more emotionally 
challenging and commonly postponed until death was imminent, especially for those without 
cancer who were less likely to be considered terminally ill. Those patients who tended to 
have a prolonged trial of aggressive treatments were mainly admitted to ICUs or other wards 
rather than PCUs. Most of the patients, however, had a lower likehood of being discharged 
alive, resulting in a high proportion of liaison palliative care services at the end of life but in a 
low utilisation of home care as observed in our data. 
European and North American studies have reported that a varied but consistently lower 
proportion of patients with dementia received tube feeding at an end-of-life stage (less than 
2% to 25%),36-38 but, in Asia, the data indicated that more than one-half of patients with 
dementia had ever been enterally fed in Hong Kong,29 Israel,39 and this Taiwanese study. 
Many family caregivers in Taiwan are deeply influenced by traditional Chinese customs and 
believe that artificial nutrition is essential to basic care and that dying patients become 
‘hungry ghosts’ if they are not provided adequate nutrition;40 these caregivers are thus usually 
reluctant to prevent the aggressive intubation of patients with dementia.6 
Kiely et al. reported that more than one-half of the residents with advanced dementia in 
long-term care facilities who were referred to hospice had an eating problem.41 Enteral tube 
insertion and feeding are predominantly performed during acute hospital referral for not only 
dysphagia but also acute infection and dehydration.42 The more frequent ED visits in the 
treatment cohort might have contributed to the insertion of enteral tubes, as it is common in 
Taiwan to continue tube feeding without swallow training once the tube has been inserted 
because of a misunderstanding of its advantages for preventing patients with dementia from 
choking and aspiration pneumonia.43 
In the 2015 Quality of Death Index report, the quality of end-of-life care in Taiwan was 
ranked high in relation to the care provided in other countries worldwide.24 However, the 
system of palliative care for patients with non-cancerous diseases in Taiwan needs urgent 
improvement; the current paradigm for initiating palliative care services should be shifted 
from considering survival prediction towards the maximisation of comfort throughout the 
entire disease course and that ACP should be initiated earlier with patients and families.1,4 In 
response to this objective, the first government-sponsored guidebook for clinical practice and 
public education on palliative care for dementia in Taiwan was edited by a domestic scientific 
committee and published in October 2016.44 At the end of 2015, Taiwan legalised the Patient 
Autonomy Act, which acknowledges the statutory role of ACP and will facilitate more 
advance decisions for patients with dementia. 
The strengths of our study include its national population-based approach, large number of 
cases, and comparative analysis matched for multiple factors. One limitation is that despite 
adjusting for the Charlson Comorbidity Index, the absence of information on disease severity 
and functional status in the database may have confounded the analysis. Second, the exact 
initiation date of liaison palliative care during hospitalisation could not be determined from 
the database, and thus, the day on which the hospital admission occurred was substituted as 
the index date. This method may have overestimated the time from the index date to death 
and might also have limited our ability to distinguish the sequence of care between liaison 
palliative care services and life-sustaining treatment. However, this bias might have been 
adjusted for after matching because the same criteria were applied to the index date for the 
comparative group. Finally, the potential for under-reporting of symptoms because of 
patients’ poor communication capacity and limitations regarding the number of diagnoses 
coded in the dataset could have contributed to an underestimation of comorbidities for the 
patients with dementia. 
Conclusion 
Palliative care for patients with dementia in Taiwan is rarely used but is associated with 
reduced life-sustaining treatments except for tube feeding and non-invasive ventilators. 
Malignancy status may influence clinicians’ and relatives’ perception of terminal illness and 
the paradigm of healthcare practice. Objectives should include: modifying the indications to 
enable the timely introduction of palliative care to patients with dementia and their relatives; 
increasing public awareness of the terminal nature of dementia; and facilitating ACP and 
shared decision-making between healthcare practitioners, patients, and their families. Further 
studies with a pre-post or randomised trial design are recommended to evaluate the 
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Figure legend 
Figure 1. Flowchart of study subject selection. NHIRD = National Health Insurance 
Research Database. 
 
Figure 2. Forest plot of the risk of life-sustaining treatments associated with palliative 
care for dementia patients with and without cancer. CI = confidence interval. HFOV = 
high frequency oscillatory ventilation. 
 
 
Table 1. Eligibility criteria for palliative care in dementia in Taiwan. 
I. Essential criteria: Clinical Dementia Rating32 (CDR) = 5  
Patients with dementia have deteriorated in terms of complete inability to 
communicate, dysphagia, total dependence on feeding (oral or tube), 
incontinence, bed-bound, and joint contracture 
II. Associated clinical conditionsa: 
Patients experience acute deterioration of one or multiple following conditions 
during their disease course 
1. Electrolyte imbalance 
2. Pain 
3. Severe dyspnoea 
4. Malignant bowel obstruction 
5. Severe vomiting 
6. Fever, suspect infection 
7. Seizure 
8. Delirium 
9. Pre-dying state 
aThese conditions are exactly the same as the eligibility criteria for the palliative care 
of cancer patients. 
Table 2. Baseline characteristics of the source population (N = 239,633) and study 
participants (n = 5,988). 
















N = 1996 
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palliative care 




   
 
  






80.02 ± 7.16 80.02 ± 7.16 







1086 (54.41) 2172 (54.41) 
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275 (53.71) 550 (53.71) 
Comorbidities, 
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1484 (74.35) 2968 (74.35) 
Other 
Characteristics 












































1054 (52.81) 2386 (59.77) 
ED (1 year 
before 
registration), n (%) 
2841 
(72.33) 
N/Ab   
416 (81.25) 686 (66.99) 
<3 times 1431 
(50.37) 
N/Ab   
300 (58.59) 779 (76.07) 
≥3 times 1410 
(49.63) 
N/Ab   
212 (41.41) 245 (23.93) 
Death, n (%) 3372 
(85.85) 
N/Ab   
1746 (87.47) 1848 (46.29) 
Time from 
index date to 
death, days 






N/Ab   
33 (15–76) 38 (10–181) 




N/Ab   
213 (12.20) 367 (19.86) 




N/Ab   
1379 (78.98) 1019 (55.14) 




N/Ab   
154 (8.82) 462 (25.00) 
ED: emergency department; N/A: not applicable; Q1: first quartile; Q3: first quartile; 
SD: standard deviation. 
ap-value was based on a Pearson’s chi-square test for categorical variables and 
Student’s t-test or Wilcoxon rank-sum test for continuous variables. 
bNot applicable because there was no defined index date for the registration of 
dementia patients who did not have palliative care for the source population.
 Table 3. Categories of palliative care services for patients with dementia. 
  N (%) Mean ± SD Median 
(Q1–Q3) 
Dementia patients who received palliative 
care (total, N = 1996; multiple categories 
possible) 
   
 Category Aa, per person, days 1150 (57.62) 17.14 ± 24.74 10 (4–21) 
 Category Bb, per person, times 888 (44.49) 1.67 ± 1.22 1 (1–2) 
 Category Cc, per person, times 679 (34.02) 13.19 ± 20.59 6 (3–15) 
 Dementia patients with cancer who 
received palliative care (N = 1484; 
multiple categories possible) 
   
 Category Aa, per person, days 881 (59.37) 18.34±26.95 10 (5-23) 
 Category Bb, per person, times 607 (40.90) 1.77±1.33 1 (1-2) 
 Category Cc, per person, times 576 (38.81) 12.37±19.15 6 (3-13) 
 Dementia patients without cancer 
who received palliative care (N = 
512; multiple categories possible) 
   
 Category Aa, per person, days 269 (52.54) 13.22 ± 14.77 8 (3–18) 
 Category Bb, per person, times 281 (54.88) 1.46 ± 0.89 1 (1–2) 
 Category Cc, per person, times 103 (20.12) 17.78 ± 26.92 10 (4–22) 
Q1: first quartile; Q3: first quartile; SD: standard deviation. 
aCategory A: Palliative care unit/hospice ward. 
bCategory B: Hospital liaison palliative care/hospice shared care, with the upper limit of 
service reimbursement: once per week. 
cCategory C: Community palliative care/hospice home care, with the upper limit of 
service reimbursement: twice per week.
 Table 4. Association between palliative care and life-sustaining interventions for 
matched cohorts of patients with dementia. 
  Dementia with 
palliative care 









insertionb, n (%) 
 1151 (57.67) 1994 (49.95) 1.42 (1.27–1.59) 
Tube feeding, n (%)  1305 (65.38) 2156 (54.01) 1.73 (1.54–1.95) 
Blood transfusionc, n 
(%) 
 855 (42.84) 1641 (41.11) 1.07 (0.95–1.20) 
Haemodialysis, n (%)  106 (5.31) 283 (7.09) 0.74 (0.56–0.96) 
Respiratory 
therapies 
    
Non-invasive 
positive pressure 
ventilatorsd, n (%) 
 217 (10.87) 386 (9.67) 1.22 (1.01–1.46) 
Mechanical 
ventilation and 
HFOV, n (%) 
 240 (12.02) 1006 (25.20) 0.41 (0.35–0.48) 
Endotracheal 
intubation, n (%) 
 171 (8.57) 827 (20.72) 0.37 (0.31–0.44) 
Tracheostomy, n 
(%) 




    
Defibrillation and 
temporary 
pacemaker, n (%) 
 13 (0.65) 98 (2.45) 0.23 (0.12–0.43) 
Cardiopulmonary 
resuscitation, n (%) 
 55 (2.76) 401 (10.05) 0.25 (0.18–0.33) 
CI: confidence interval. HFOV: high frequency oscillatory ventilation. 
aAdjusted for confounding covariates including comorbidities. 
bIncluded nasogastric tube insertions, gastrostomy, and jejunostomy. 
cWhole blood or packed red blood cell transfusion. 
dIncluded Nasal PAP (positive airway pressure), CPAP (continuous positive airway 
pressure), and Bi-PAP (bi-level positive airway pressure). 
